Skip to content

Embecta Corp. EMBC Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

AdaptHealth logo
AdaptHealthAHCO
Baxter International logo
Baxter InternationalBAX
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s interest income (expense), nonoperating?
Embecta Corp. (EMBC) reported interest income (expense), nonoperating of -$22.6M in Q1 2026.
How has Embecta Corp.'s interest income (expense), nonoperating changed year-over-year?
Embecta Corp.'s interest income (expense), nonoperating increased by 15.4% year-over-year, from -$26.7M to -$22.6M.
What is the long-term trend for Embecta Corp.'s interest income (expense), nonoperating?
Over 3 years (2022 to 2025), Embecta Corp.'s interest income (expense), nonoperating has grown at a 32.4% compound annual growth rate (CAGR), from -$46.2M to -$107.3M.